From: Using description logics to evaluate the consistency of drug-class membership relations in NDF-RT
Drug perspective | Baseline | + Disease | Delta | ||
---|---|---|---|---|---|
# drugs with | Abs. | % | Abs. | % | |
Identical sets | 657 | 52.06 | 660 | 50.46 | 3 |
Compatible sets | 122 | 9.67 | 127 | 9.71 | 5 |
Additional asserted | 66 | 5.23 | 68 | 5.20 | 2 |
Additional inferred | 18 | 1.43 | 73 | 5.58 | 55 |
Additional in both | 18 | 1.43 | 35 | 2.68 | 17 |
Asserted only | 379 | 30.03 | 297 | 22.71 | −82 |
Inferred only | 2 | 0.16 | 48 | 3.67 | 46 |
Total # drugs | 1262 | 100 | 1308 | 100 | 46 |
Total # pairs | 1569 | 1696 | 127 | ||
Drug class perspective | Baseline | + Disease | Delta | ||
# classes with | Abs. | % | Abs. | % | |
Identical sets | 237 | 51.19 | 242 | 52.27 | 5 |
Additional asserted | 40 | 8.64 | 55 | 11.88 | 15 |
Additional inferred | 19 | 4.10 | 20 | 4.32 | 1 |
Additional in both | 5 | 1.08 | 18 | 3.89 | 13 |
Asserted only | 157 | 33.91 | 123 | 26.57 | −34 |
Inferred only | 5 | 1.08 | 5 | 1.08 | 0 |
Total # classes | 463 | 100 | 463 | 100 | 0 |
Total # pairs | 2259 | 2392 | 133 |